C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 215/42 (2006.01) A61K 31/47 (2006.01) A61K 31/495 (2006.01) A61K 31/53 (2006.01) A61K 31/535 (2006.01) A61K 31/54 (2006.01) A61K 31/55 (2006.01) C07D 401/12 (2006.01) C07D 405/12 (2006.01) C07D 409/12 (2006.01) C07D 471/04 (2006.01) C07D 473/00 (2006.01) C07D 475/00 (2006.01)
Patent
CA 2282183
Cholesteryl ester transfer protein inhibitors, pharmaceutical compositions containing such inhibitors and the use of such inhibitors to elevate certain plasma lipid levels, including high density lipoprotein-cholesterol and to lower certain other plasma lipid levels, such as LDL-cholesterol and triglycerides and accordingly to treat diseases which are exacerbated by low levels of HDL cholesterol and/or high levels of LDL- cholesterol and triglycerides, such as atherosclerosis and cardiovascular diseases in some mammals, including humans.
Goldstein Steven Wayne
Makowski Michael Raymond
Ruggeri Roger Benjamin
Wester Ronald Thure
Pfizer Products Inc.
Smart & Biggar
LandOfFree
Oxy substituted... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oxy substituted..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oxy substituted... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2013848